Early toxicity of hypofractionated radiotherapy for prostate cancer

Authors	KRUPA Pavel TICHA Hana KAZDA Tomáš DYMÁČKOVÁ Radana ZITTEBARTOVÁ Jana ODLOZILIKOVA Anna KOMINEK Libor BOBEK Lukas KUDLACEK Ales ŠLAMPA Pavel
Year of publication	2016
Type	Article in Periodical
Magazine / Source	Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc, Czech Republic
MU Faculty or unit	Faculty of Medicine
Citation
Doi	http://dx.doi.org/10.5507/bp.2016.008
Field	Oncology and hematology
Keywords	hypofractionationation; VMAT; volumetric arc therapy; RapidArc; Tumor control probability; Normal tissue complication probability; alternated time schedule
Description	Hypofractionated accelerated radiotherapy (HART) is now a feasible option for prostate cancer treatment apropos toxicity, biochemical control and shortening of treatment. The aim of this study was to investigate hypofractionated schedules in the treatment of patients with localized prostate cancer.